These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22705888)

  • 1. Preventing platelet thrombosis with a PAR1 pepducin.
    Abdel-Latif A; Smyth SS
    Circulation; 2012 Jul; 126(1):13-5. PubMed ID: 22705888
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticoagulant and antithrombotic properties of intracellular protease-activated receptor antagonists.
    Wielders SJ; Bennaghmouch A; Reutelingsperger CP; Bevers EM; Lindhout T
    J Thromb Haemost; 2007 Mar; 5(3):571-6. PubMed ID: 17166251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of arterial thrombosis without affecting hemostatic parameters with a cell-penetrating PAR1 pepducin.
    Zhang P; Gruber A; Kasuda S; Kimmelstiel C; O'Callaghan K; Cox DH; Bohm A; Baleja JD; Covic L; Kuliopulos A
    Circulation; 2012 Jul; 126(1):83-91. PubMed ID: 22705889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-Penetrating Pepducin Therapy Targeting PAR1 in Subjects With Coronary Artery Disease.
    Gurbel PA; Bliden KP; Turner SE; Tantry US; Gesheff MG; Barr TP; Covic L; Kuliopulos A
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):189-97. PubMed ID: 26681756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease-Activated Receptor 1 Inhibitors: Novel Antiplatelet Drugs in Prevention of Atherothrombosis.
    Al-Khafaji K; Mutyala M; Al-Khafaji N; Harper Y; Ismail I; Hakim H; Arora RR
    Am J Ther; 2017; 24(6):e730-e736. PubMed ID: 26398717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approval of the first protease-activated receptor antagonist: Rationale, development, significance, and considerations of a novel anti-platelet agent.
    French SL; Arthur JF; Tran HA; Hamilton JR
    Blood Rev; 2015 May; 29(3):179-89. PubMed ID: 25467961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The platelet--thrombosis and beyond.
    Langer HF; Weber C; Gawaz M
    Thromb Haemost; 2013 Nov; 110(5):857-8. PubMed ID: 24108387
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms of platelet activation by thrombin: a short history.
    De Candia E
    Thromb Res; 2012 Mar; 129(3):250-6. PubMed ID: 22137742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PAR1 antagonist, SCH79797, alters platelet morphology and function independently of PARs.
    Lee H; Hamilton JR
    Thromb Haemost; 2013 Jan; 109(1):164-7. PubMed ID: 23093354
    [No Abstract]   [Full Text] [Related]  

  • 10. Platelet receptors as therapeutic targets: Past, present and future.
    Jamasbi J; Ayabe K; Goto S; Nieswandt B; Peter K; Siess W
    Thromb Haemost; 2017 Jun; 117(7):1249-1257. PubMed ID: 28597906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosis.
    Leger AJ; Jacques SL; Badar J; Kaneider NC; Derian CK; Andrade-Gordon P; Covic L; Kuliopulos A
    Circulation; 2006 Mar; 113(9):1244-54. PubMed ID: 16505172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin receptor antagonism -the potential of antiplatelet medication SCH 530348.
    Macaulay TE; Allen C; Ziada KM
    Expert Opin Pharmacother; 2010 Apr; 11(6):1015-22. PubMed ID: 20307225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editors' Choice papers in Thrombosis and Haemostasis.
    Weber C; Lip GY
    Thromb Haemost; 2015 Jan; 113(1):217-20. PubMed ID: 25567474
    [No Abstract]   [Full Text] [Related]  

  • 14. The ATP-gated P2X1 receptor plays a pivotal role in activation of aspirin-treated platelets by thrombin and epinephrine.
    Grenegård M; Vretenbrant-Oberg K; Nylander M; Désilets S; Lindström EG; Larsson A; Ramström I; Ramström S; Lindahl TL
    J Biol Chem; 2008 Jul; 283(27):18493-504. PubMed ID: 18480058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa-Driven Platelet Activation via Protease Activated Receptor-1.
    Petzold T; Thienel M; Dannenberg L; Mourikis P; Helten C; Ayhan A; M'Pembele R; Achilles A; Trojovky K; Konsek D; Zhang Z; Regenauer R; Pircher J; Ehrlich A; Lüsebrink E; Nicolai L; Stocker TJ; Brandl R; Röschenthaler F; Strecker J; Saleh I; Spannagl M; Mayr CH; Schiller HB; Jung C; Gerdes N; Hoffmann T; Levkau B; Hohlfeld T; Zeus T; Schulz C; Kelm M; Polzin A
    Circ Res; 2020 Feb; 126(4):486-500. PubMed ID: 31859592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Protease-Activated Receptor (PAR1) Reduces Activation of the Endothelium, Coagulation, Fibrinolysis and Inflammation during Human Endotoxemia.
    Schoergenhofer C; Schwameis M; Gelbenegger G; Buchtele N; Thaler B; Mussbacher M; Schabbauer G; Wojta J; Jilma-Stohlawetz P; Jilma B
    Thromb Haemost; 2018 Jul; 118(7):1176-1184. PubMed ID: 29864779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in-vitro effects of E5555, a protease-activated receptor (PAR)-1 antagonist, on platelet biomarkers in healthy volunteers and patients with coronary artery disease.
    Serebruany VL; Kogushi M; Dastros-Pitei D; Flather M; Bhatt DL
    Thromb Haemost; 2009 Jul; 102(1):111-9. PubMed ID: 19572075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
    Jennings LK
    Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer.
    Cisowski J; O'Callaghan K; Kuliopulos A; Yang J; Nguyen N; Deng Q; Yang E; Fogel M; Tressel S; Foley C; Agarwal A; Hunt SW; McMurry T; Brinckerhoff L; Covic L
    Am J Pathol; 2011 Jul; 179(1):513-23. PubMed ID: 21703428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vorapaxar, a Protease-Activated Receptor-1 Antagonist, a Double-Edged Sword!
    Bhandari B; Mehta B
    Recent Adv Cardiovasc Drug Discov; 2014; 9(2):73-7. PubMed ID: 26104312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.